Send feedback

AMPD1 p.Arg425Cys

c.1273C>T · rs187527797 · VCV1521611

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.914 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00288%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, REVEL
Conditions
1
myopathy due to myoadenylate deaminase deficiency

Computational evidence

Protein change
AlphaMissense0.914likely pathogenic
REVEL0.871moderately pathogenic-leaning
⇒ AlphaMissense and REVEL both call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.6, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 21 kb · p 0.9 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R458C vs ClinVar R425C) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00288% European (non-Finnish) · 34/1,179,838 alleles
Filtering AF 0.00207% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00183%
Overall 0.00229% 37/1,613,166 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,600
European (non-Finnish)grpmax 0.00288% 34,701
East Asian 0.00223% 44,830
Admixed American 0.00167% 59,870

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AMPD1
Protein
p.Arg425Cys
Coding
c.1273C>T
MANE Select
NM_000036
dbSNP
rs187527797
Type
single nucleotide variant
Location
chr1:114677466 (GRCh38)
Gene constraint
LOEUF 1.036 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 86.84
Residue 425
a UniProt-annotated variant site (in mmdd; loss of amp deaminase activity)
Full AMPD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ampd1-p-arg425cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown